Back to PACB
FARALLON CAPITAL MANAGEMENT, L.L.C. → PACB
FARALLON CAPITAL MANAGEMENT, L.L.C. PACB Position History
Pacific Biosciences of California, Inc.
Quarters held
15
Latest value
$24K
Q2 2026
Peak value
$110.9M
First seen
Q2 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2023 | $110.9M |
| Q3 2023 | $85.4M |
| Q4 2023 | $60.7M |
| Q1 2024 | $14.1M |
| Q1 2024 | $14.1M |
| Q2 2024 | $185K |
| Q3 2024 | $230K |
| Q4 2024 | $247K |
| Q1 2025 | $159K |
| Q2 2025 | $167K |
| Q3 2025 | $173K |
| Q3 2025 | $173K |
| Q4 2025 | $252K |
| Q1 2026 | $178K |
| Q2 2026 | $24K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $24K | 14.2K | — | — |
| Q1 2026 | $178K | 135.0K | — | — |
| Q4 2025 | $252K | 135.0K | — | — |
| Q3 2025 | $173K | 135.0K | — | — |
| Q3 2025 | $173K | 135.0K | — | — |
| Q2 2025 | $167K | 135.0K | — | — |
| Q1 2025 | $159K | 135.0K | — | — |
| Q4 2024 | $247K | 135.0K | — | — |
| Q3 2024 | $230K | 135.0K | — | — |
| Q2 2024 | $185K | 135.0K | — | — |
| Q1 2024 | $14.1M | 3.77M | — | — |
| Q1 2024 | $14.1M | 3.77M | — | — |
| Q4 2023 | $60.7M | 6.19M | — | — |
| Q3 2023 | $85.4M | 10.22M | — | — |
| Q2 2023 | $110.9M | 8.34M | — | — |